Compare Apple Inc (AAPL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Apple Inc vs Zimmer Biomet Holdings Inc — how do they compare? Apple Inc trades at $312.47 (market cap $4.56T), while Zimmer Biomet Holdings Inc trades at $88.58 (market cap $17.30B). The key difference: Apple Inc is far larger — about 263.6× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.
| AAPL | ZBH | |
|---|---|---|
Market Cap | $4.56T | $17.30B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $315.20 | $107.71 |
52-Week Low | $202.38 | $79.58 |
Enterprise Value | $4.58T | $24.34B |
Dividend Yield | 0.35% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Apple (AAPL) trades at $310.09, down 0.82% on the day, with a bullish technical signal from moving averages and strong institutional support. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $2.01 exceeding the $1.95 estimate. Revenue for 2025 reached $416.16 billion, driving a net income margin of 26.91%. Analysts maintain a consensus buy rating with a $329.62 price target, citing Apple's massive device base as an AI opportunity.
The outlook remains positive given earnings momentum and a $0.27 dividend, but risks include potential Q2 2026 earnings miss concerns and union disputes. Valuation multiples like P/E of 37.61 suggest premium pricing, requiring sustained growth to justify upside. Institutional holdings show mixed activity, with some trimming positions amid high RSI levels indicating overbought conditions near-term.
Zimmer Biomet (ZBH) trades at $89.41, up 2.22% with a bullish technical signal and consistent earnings beats. The stock shows strong fundamentals with 70% gross margins and revenue growth to $8.23B in 2025, though net margins compressed to 8.56%. Recent developments include a $140M acquisition and plans to hire 500 tech employees in India, supporting growth initiatives. Valuation metrics appear reasonable with P/E of 23.25 and P/S of 2.11.
ZBH offers moderate upside to the $98.33 consensus target with analyst sentiment mixed (43% buy, 50% hold). Key risks include rising debt levels (debt-to-asset ratio increased to 32.57% in 2025) and margin pressure. The company's $1B share repurchase program and dividend provide shareholder returns, but execution on growth initiatives remains critical for sustained outperformance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
